In addition to APP, inhibition of NFE2L2, IFNG, TGFB1, CREB1 and TNF, seems to directly regulate the decrease in the inflammatory response of OHCs in TD (Additional file 4). The gene discussed is TNF; the disease is thanatophoric dysplasia.